Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study

NCT02585934 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1315

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: RVT-101
DRUG: Placebo

Sponsor

Axovant Sciences Ltd.